EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A

Folake A Egbewande, Brett D Schwartz, Sandra Duffy, Vicky M Avery iD, Rohan A Davis iD

Marine Drugs · 2023

DOI: 10.3390/md21050317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Folake A Egbewande und 4 weiteren Autor:innen. Beteiligte Einrichtung: Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Nathan, QLD 4111, Australia. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Falciparum, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council, Medicines for Malaria Venture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incorporation of bromine, iodine or fluorine into the tricyclic core structure of thiaplakortone A (1), a potent antimalarial marine natural product, is reported. Although yields were low, it was possible to synthesise a small nine-membered library using the previously synthesised Boc-protected thiaplakortone A (2) as a scaffold for late-stage functionalisation. The new thiaplakortone A analogues (3–11) were generated using N-bromosuccinimide, N-iodosuccinimide or a Diversinate™ reagent. The chemical structures of all new analogues were fully characterised by 1D/2D NMR, UV, IR and MS data analyses. All compounds were evaluated for their antimalarial activity against Plasmodium falciparum 3D7 (drug-sensitive) and Dd2 (drug-resistant) strains. Incorporation of halogens at positions 2 and 7 of the thiaplakortone A scaffold was shown to reduce antimalarial activity compared to the natural product. Of the new compounds, the mono-brominated analogue (compound 5) displayed the best antimalarial activity with IC50 values of 0.559 and 0.058 μM against P. falciparum 3D7 and Dd2, respectively, with minimal toxicity against a human cell line (HEK293) observed at 80 μM. Of note, the majority of the halogenated compounds showed greater efficacy against the P. falciparum drug-resistant strain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalaria, FalciparumBiological ProductsHumansHEK293 CellsTriazinesPlasmodium falciparum

Stichwörter der Autor:innen

Diversinate™N-bromosuccinimideN-iodosuccinimidePlasmodiumbiodiscoveryhalogenationlate-stage functionalizationlibrarymalarianatural productsulfinatethiaplakortone A

Substanzen

Antimalarialsthiaplakortone ATriazinesBiological Products

Autor:innen und Institutionen

  • Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Nathan, QLD 4111, Australia.
  • Discovery Biology, Centre for Cellular Phenomics, Griffith University, Nathan, QLD 4111, Australia.
  • NatureBank, Griffith University, Nathan, QLD 4111, Australia.

ORCID-Profile: Vicky M Avery, Rohan A Davis

Förderung

  • National Health and Medical Research Council
  • Australian Research Council
  • Medicines for Malaria Venture

Zitieren

APA

Egbewande, F. A., Schwartz, B. D., Duffy, S., Avery, V. M., & Davis, R. A. (2023). Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A. Marine Drugs. https://doi.org/10.3390/md21050317

Vancouver

Egbewande FA, Schwartz BD, Duffy S, Avery VM, Davis RA. Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A. Marine Drugs. 2023. doi:10.3390/md21050317

BibTeX
@article{Egbewande2023,
  author = {Egbewande, Folake A and Schwartz, Brett D and Duffy, Sandra and Avery, Vicky M and Davis, Rohan A},
  title = {Synthesis and Antimalarial Evaluation of Halogenated Analogues of Thiaplakortone A},
  journal = {Marine Drugs},
  year = {2023},
  doi = {10.3390/md21050317}
}
Kostenlos starten →